Genprex Provides Clinical, Corporate, and Financial Update for the Year Ending December 31, 2018
AUSTIN, Texas & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company developing a new approach to treating…